FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Crowley

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Joseph M Unger; Kathy S Albain; Kenda Burg; Dawn L Hershman; Carol M Moinpour; Judith A Petersen; John J Crowley
Patient income level and cancer clinical trial participation.
Phyllis J Goodman; Jo Ann Hartline; Eric A Klein; Frank L Meyskens; Lori M Minasian; Catherine M Tangen; Monica Yee; Karen Anderson; Kathryn B Arnold; Elise D Cook; John J Crowley; Amy K Darke; Laurence H Baker
Moving a randomized clinical trial into an observational cohort.
Roy S Herbst; Karen Kelly; Kari Chansky; Philip C Mack; Wilbur A Franklin; Fred R Hirsch; James N Atkins; Shaker R Dakhil; Kathy S Albain; Edward S Kim; Mary Redman; John J Crowley; David R Gandara
Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Crowley (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Joseph M Unger; Kathy S Albain; Kenda Burg; Dawn L Hershman; Carol M Moinpour; Judith A Petersen; John J Crowley
Patient income level and cancer clinical trial participation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(5):536-42.
2013: Phyllis J Goodman; Jo Ann Hartline; Eric A Klein; Frank L Meyskens; Lori M Minasian; Catherine M Tangen; Monica Yee; Karen Anderson; Kathryn B Arnold; Elise D Cook; John J Crowley; Amy K Darke; Laurence H Baker
Moving a randomized clinical trial into an observational cohort.
Clinical trials (London, England) 2013;10(1):131-42.
2010: Roy S Herbst; Karen Kelly; Kari Chansky; Philip C Mack; Wilbur A Franklin; Fred R Hirsch; James N Atkins; Shaker R Dakhil; Kathy S Albain; Edward S Kim; Mary Redman; John J Crowley; David R Gandara
Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(31):4747-54.
2010: Katherine M W Pisters; Eric Vallières; John J Crowley; Wilbur A Franklin; Paul A Bunn; Robert J Ginsberg; Joe B Putnam; Kari Chansky; David R Gandara
Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(11):1843-9.
2009: Quynh-Thu Le; James Moon; Mary Redman; Stephen K Williamson; Primo Lara; Zelanna Goldberg; Laurie E Gaspar; John J Crowley; Dennis F Moore; David R Gandara
Phase II study of tirapazamine, cisplatin, and etoposide and concurrent thoracic radiotherapy for limited-stage small-cell lung cancer: SWOG 0222.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3014-9.
2008: Philip C Mack; Mary W Redman; Kari Chansky; Stephen K Williamson; Nichole C Farneth; Primo Lara; Wilbur A Franklin; Quynh-Thu Le; John J Crowley; David R Gandara
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4771-6.
2008: Karen Kelly; Kari Chansky; Laurie E Gaspar; Kathy S Albain; James Jett; Yee C Ung; Derick H Lau; John J Crowley; David R Gandara
Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(15):2450-6.
2008: Primo Lara; Mary W Redman; Karen Kelly; Martin J Edelman; Stephen K Williamson; John J Crowley; David R Gandara
Disease control rate at 8 weeks predicts clinical benefit in advanced non-small-cell lung cancer: results from Southwest Oncology Group randomized trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):463-7.
2007: Wallace Akerley; Jason McCoy; Paul J Hesketh; J Wendall Goodwin; James Bearden; James N Atkins; Kari Chansky; John J Crowley; David R Gandara
Gemcitabine and irinotecan for patients with untreated extensive stage small cell lung cancer: SWOG 0119.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(6):526-30.
2007: Paul J Hesketh; Rogerio Lilenbaum; Kari Chansky; Afshin Dowlati; Patricia Graham; Robert A Chapman; John J Crowley; David R Gandara
Chemotherapy in patients > or = 80 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(6):494-8.
2007: Paul J Hesketh; Kari Chansky; Valerie Israel; Richard T Grapski; Tarek M Mekhail; C Harris Spiridonidis; Glenn M Mills; Karen Kelly; John J Crowley; David R Gandara
Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group Study 9718.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2007;2(5):440-4.
2006: Angela M Davies; Kari Chansky; Derick H Lau; Bryan R Leigh; Laurie E Gaspar; Geoffrey R Weiss; Antoinette J Wozniak; John J Crowley; David R Gandara
Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5242-6.
2006: Primo Lara; Kari Chansky; Angela M Davies; Wilbur A Franklin; Paul H Gumerlock; Perry P Guaglianone; James N Atkins; Nichole Farneth; Philip C Mack; John J Crowley; David R Gandara
Bortezomib (PS-341) in relapsed or refractory extensive stage small cell lung cancer: a Southwest Oncology Group phase II trial (S0327).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9):996-1001.
2006: Paul J Hesketh; Jason McCoy; Frank R Dunphy; James Bearden; Geoffrey R Weiss; Jeffrey K Giguere; James N Atkins; Shaker R Dakhil; Karen Kelly; John J Crowley; David R Gandara
Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(9):991-5.
2006: Paul J Hesketh; Kari Chansky; Derick H Lau; James Doroshow; Carol M Moinpour; Robert A Chapman; J Wendall Goodwin; Howard M Gross; John J Crowley; David R Gandara
Sequential vinorelbine and docetaxel in advanced non-small cell lung cancer patients age 70 and older and/or with a performance status of 2: a phase II trial of the Southwest Oncology Group (S0027).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2006;1(6):537-44.
2006: Phyllis J Goodman; Ian M Thompson; Catherine M Tangen; John J Crowley; Leslie G Ford; Charles A Coltman
The prostate cancer prevention trial: design, biases and interpretation of study results.
The Journal of urology 2006;175(6):2234-42.
2006: Howard L West; Wilbur A Franklin; Jason McCoy; Paul H Gumerlock; Ralph Vance; Derick H Lau; Kari Chansky; John J Crowley; David R Gandara
Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1807-13.
2006: Joseph M Unger; Charles A Coltman; John J Crowley; Laura F Hutchins; Silvana Martino; Robert B Livingston; John S Macdonald; Charles D Blanke; David R Gandara; E David Crawford; Kathy S Albain
Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(1):141-4.
2005: Stephen K Williamson; John J Crowley; Primo Lara; Jason McCoy; Derick H Lau; Robert W Tucker; Glenn M Mills; David R Gandara
Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non-small-cell lung cancer: Southwest Oncology Group Trial S0003.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9097-104.
2005: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.
JAMA : the journal of the American Medical Association 2005;294(1):66-70.
2005: Howard L West; John J Crowley; R B Vance; Wilbur A Franklin; Robert B Livingston; Shaker R Dakhil; Jeffrey K Giguere; Saul E Rivkin; M Kraut; Kari Chansky; David R Gandara
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(7):1076-80.
2005: Philip R Greipp; Jesús San Miguel; Brian G M Durie; John J Crowley; Bart Barlogie; Joan Bladé; Mario Boccadoro; J Anthony Child; Hervé Avet-Loiseau; Jean-Luc Harousseau; Robert A Kyle; Juan José Lahuerta; Heinz Ludwig; Gareth Morgan; Raymond Powles; Kazuyuki Shimizu; Chaim Shustik; Pieter Sonneveld; Patrizia Tosi; Ingemar Turesson; Jan Westin
International staging system for multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3412-20.
2005: Joseph M Unger; Ian M Thompson; Michael LeBlanc; John J Crowley; Phyllis J Goodman; Leslie G Ford; Charles A Coltman
Estimated impact of the Prostate Cancer Prevention Trial on population mortality.
Cancer 2005;103(7):1375-80.
2005: Scott M Lippman; Phyllis J Goodman; Eric A Klein; Howard L Parnes; Ian M Thompson; Alan R Kristal; Regina M Santella; Jeffrey L Probstfield; Carol M Moinpour; Demetrius Albanes; Philip R Taylor; Lori M Minasian; Ashraful Hoque; Sarah Moody Thomas; John J Crowley; J Michael Gaziano; Janet L Stanford; Elise D Cook; Neil E Fleshner; Michael M Lieber; Philip J Walther; Fadlo R Khuri; Daniel D Karp; Gary G Schwartz; Leslie G Ford; Charles A Coltman
Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Journal of the National Cancer Institute 2005;97(2):94-102.
2004: Quynh-Thu Le; Jason McCoy; Stephen Williamson; Janice Ryu; Laurie E Gaspar; Martin J Edelman; Shaker R Dakhil; Stanley D Sides; John J Crowley; David R Gandara
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(16):5418-24.
2004: Tatsuo Kimura; Will S Holland; Tomoya Kawaguchi; Stephen K Williamson; Kari Chansky; John J Crowley; James Doroshow; Heinz-Josef Lenz; David R Gandara; Paul H Gumerlock
Mutant DNA in plasma of lung cancer patients: potential for monitoring response to therapy.
Annals of the New York Academy of Sciences 2004;1022():55-60.
2004: Ian M Thompson; Donna K Pauler; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Howard L Parnes; Lori M Minasian; Leslie G Ford; Scott M Lippman; E David Crawford; John J Crowley; Charles A Coltman
Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.
The New England journal of medicine 2004;350(22):2239-46.
2004: Phyllis J Goodman; Catherine M Tangen; John J Crowley; Susan M Carlin; Anne Ryan; Charles A Coltman; Leslie G Ford; Ian M Thompson
Implementation of the Prostate Cancer Prevention Trial (PCPT).
Controlled clinical trials 2004;25(2):203-22.
2004: Catherine M Tangen; Phyllis J Goodman; John J Crowley; Ian M Thompson
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials.
The Journal of urology 2004;171(2 Pt 2):S64-7.
2003: Joseph M Unger; Michael LeBlanc; John J Crowley; H Barton Grossman; Ronald B Natale; Antoinette J Wozniak; James R Berenson; Alan F List; William A Peters; Robert C Flanigan; John S Macdonald; Muhyi Al-Sarraf; Ian M Thompson; Charles A Coltman
Estimating the impact of new clinical trial proven cancer therapy and cancer chemoprevention on population mortality: the Karnofsky Memorial lecture.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23 Suppl):246s-252s.
2003: Joth L Jacobson; Mohamad A Hussein; Bart Barlogie; Brian G M Durie; John J Crowley
A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience.
British journal of haematology 2003;122(3):441-50.
2003: Ian M Thompson; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Gary J Miller; Leslie G Ford; Michael M Lieber; R. Duane Duane Cespedes; James N Atkins; Scott M Lippman; Susie M Carlin; Anne Ryan; Connie M Szczepanek; John J Crowley; Charles A Coltman
The influence of finasteride on the development of prostate cancer.
The New England journal of medicine 2003;349(3):215-24.
2003: Madhav V Dhodapkar; Joth L Jacobson; Morie A Gertz; John J Crowley; Bart Barlogie
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
Seminars in oncology 2003;30(2):220-5.
2002: Donna K Pauler; Kathryn B Gower; Phyllis J Goodman; John J Crowley; Ian M Thompson
Biomarker-based methods for determining noncompliance in a prevention trial.
Controlled clinical trials 2002;23(6):675-85.
2002: Scott D Ramsey; Carol M Moinpour; Laura C Lovato; John J Crowley; Patra Grevstad; Cary A Presant; Saul E Rivkin; Karen Kelly; David R Gandara
Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Journal of the National Cancer Institute 2002;94(4):291-7.
2001: Ashraful Hoque; Demetrius Albanes; Scott M Lippman; Margaret R Spitz; Philip R Taylor; Eric A Klein; Ian M Thompson; Phyllis Goodman; J L Stanford; John J Crowley; Charles A Coltman; Regina M Santella
Molecular epidemiologic studies within the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
Cancer causes & control : CCC 2001;12(7):627-33.
2001: Charles Thomas; Dorothy J Giroux; L M Janaki; A T Turrisi; John J Crowley; Sarah A Taylor; J D McCracken; P G Shankir Giri; W Gordon; Robert B Livingston; David R Gandara
Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin-etoposide and daily thoracic radiotherapy in limited small-cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;33(2-3):213-9.
2001: Madhav V Dhodapkar; Joth L Jacobson; Morie A Gertz; S E Rivkin; David G Roodman; Joseph M Tuscano; M Shurafa; R A Kyle; John J Crowley; Bart Barlogie
Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: results of United States intergroup trial (Southwest Oncology Group S9003).
Blood 2001;98(1):41-8.
2000: Katherine M W Pisters; R J Ginsberg; Dorothy J Giroux; Joe B Putnam; Mark G Kris; D H Johnson; J R Roberts; J Mault; John J Crowley; P A Bunn
Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
The Journal of thoracic and cardiovascular surgery 2000;119(3):429-39.
1999: Paul J Hesketh; John J Crowley; H A Burris; Stephen K Williamson; Stanley P Balcerzak; D Peereboom; J Wendall Goodwin; Howard M Gross; D F Moore; R B Livingston; David R Gandara
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial.
The cancer journal from Scientific American 1999;5(4):237-41.
1998: Derick H Lau; John J Crowley; David R Gandara; Mark Hazuka; Kathy S Albain; Bryan R Leigh; W S Fletcher; Keith S Lanier; W L Keiser; Robert B Livingston
Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3078-81.
1998: Antoinette J Wozniak; John J Crowley; Stanley P Balcerzak; Geoffrey R Weiss; C Harris Spiridonidis; Laurence H Baker; Kathy S Albain; Karen Kelly; Sarah A Taylor; David R Gandara; Robert B Livingston
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2459-65.
1998: Charles Thomas; Dorothy J Giroux; Keith J Stelzer; J B Craig; L R Laufman; Sarah A Taylor; J Wendall Goodwin; John J Crowley; Robert B Livingston
Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
International journal of radiation oncology, biology, physics 1998;40(5):1039-47.
1998: Sydney E Salmon; John J Crowley; S P Balcerzak; R W Roach; Sarah A Taylor; Saul E Rivkin; Wolfram E Samlowski
Interferon versus interferon plus prednisone remission maintenance therapy for multiple myeloma: a Southwest Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):890-6.
1997: Katherine M W Pisters; Mark G Kris; P A Bunn; D H Johnson; John Ruckdeschel; John J Crowley; R J Ginsberg
Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.
Seminars in oncology 1997;24(4 Suppl 12):S12-41-S12-44.
1997: Celestia S Higano; John J Crowley; R V Veith; Robert B Livingston
A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.
Investigational new drugs 1997;15(2):153-6.
1995: K Kelly; John J Crowley; P A Bunn; M B Hazuka; K Beasley; C Upchurch; G R Weiss; W J Hicks; David R Gandara; S Rivkin
Role of recombinant interferon alfa-2a maintenance in patients with limited-stage small-cell lung cancer responding to concurrent chemoradiation: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2924-30.
1995: Kathy S Albain; Valerie W Rusch; John J Crowley; T W Rice; A T Turrisi; J K Weick; VA Lonchyna; C A Presant; R J McKenna; David R Gandara
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1880-92.
1993: Kathy S Albain; John J Crowley; Laura F Hutchins; David R Gandara; R M O'Bryan; Daniel Von Hoff; B Griffin; Robert B Livingston
Predictors of survival following relapse or progression of small cell lung cancer. Southwest Oncology Group Study 8605 report and analysis of recurrent disease data base.
Cancer 1993;72(4):1184-91.
1991: Kathy S Albain; John J Crowley; M LeBlanc; Robert B Livingston
Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1618-26.
1991: Kathy S Albain; John J Crowley; Robert B Livingston
Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience.
Chest 1991;99(6):1425-32.
1990: Kathy S Albain; John J Crowley; M LeBlanc; Robert B Livingston
Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(9):1563-74.